400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
2017-03-13
FDA-2011-N-0143
指导原则
美国
现行有效
/
美国食品药品监督管理局(FDA)
GUIDANCE DOCUMENT
This guidance specifies FDA’s current thinking on what unique facility identifier (UFI) FDA recognizes as acceptable for purposes of the Foreign Supplier Verification Programs (FSVP) regulation established in Title 21 of the Code of Federal Regulation, Part 1, subpart L as part of our implementation of the FDA Food Safety Modernization Act (FSMA; Pub. L. 111-353).
The pronoun “you” is used in this guidance to refer to the importer.
FDA’s guidance documents, including this guidance, do not establish legally enforceable responsibilities.
Instead, guidances describe the Agency’s current thinking on a topic and should be viewed only as recommendations, unless specific regulatory or statutory requirements are cited.
The use of the word should in Agency guidances means that something is suggested or recommended, but not required.
You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))
If unable to submit comments online, please mail written comments to:
Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852
All written comments should be identified with this document's docket number: FDA-2011-N-0143.
摩熵医械2025-11-28
摩熵医械2025-11-17
赛柏蓝2025-11-14
摩熵医械2025-11-12
赛柏蓝2025-11-12
CHC医疗传媒2025-10-30
赛柏蓝2025-10-29
赛柏蓝2025-10-28
赛柏蓝2025-10-24
赛柏蓝2025-10-24
2025-12-01
2025-11-27
2025-11-26
2025-11-24
2025-11-24
2025-11-21
2025-11-18
2025-11-18
2025-11-17
2025-11-13
2025-11-13
2025-11-13
2025-11-11
2025-11-11
2025-11-11
2024-11-15
2024-11-14
2024-11-01
2024-10-31
2024-10-30
2024-10-24
2024-10-22
2024-10-21
2024-10-17
2024-10-17
2024-10-17
2024-10-17
2024-10-17
2024-10-16
2024-10-15
2025-11-17
2025-09-17
2025-09-17
2025-09-17
2025-07-21
2025-02-05
2025-01-31
2025-01-31
2025-01-07
2025-01-07
2025-01-07
2025-01-07
2025-01-07
2025-01-07
2025-01-07